Elevated intraocular levels of insulin-like growth factor I in a diabetic patient with acromegaly

References

• Andersson D, Faber P, Marcovitz S, Hardy J, Lorenzetti D. Pituitary tumors and the ophthalmologist. Ophthalmology. 1983;90:1265–1270.
   Google Scholar
• Clemmons DR, Van Wyk JJ, Ridgway EC, Kleeman B, Kjellberg RN, Underwood LE. Evaluation of acromegaly by measurement of somatomedin C. N Engl J Med. 1979;301:1138–1142.
   PubMed Web of Science ®Google Scholar
• Hall K, Sara VR. Somatomedin levels in childhood, adolescence and in adult life. Clin Endocrinol Metabol. 1984;13:91–112.
   PubMedGoogle Scholar
• Arosio M, Bazzoni N, Faglia G. Treatment of acromegaly with octreotide, a synthetic analog of somatostatin with extended action. Minerva Endocrinol. 1990;15:29–36.
   Google Scholar
• Gerhardinger C, McClure KD, Romeo G, Podesta F, Lorenzi M. IGF-I mRNA and signalling in the diabetic retina. Diabetes. 2001;50: 175–183.
   Google Scholar
• Chen HS, Lin HD. Serum IGF-I and IGFBP-3 levels for the assessment of disease activity of acromegaly. J Endocrinol Invest. 1999;22:98–103.
   PubMed Web of Science ®Google Scholar
• Merimee TJ, Zapf J, Froesch ER. Insulin-like growth factors. Studies in diabetics without retinopathy. N Engl J Med. 1983;309:527–530.
   Google Scholar
• Lanes R, Recker B, Fort P, Lifshitz E Impaired somatomedin generation test in children with insulin dependent diabetes mellitus. Diabetes. 1985;34:156–160.
   PubMed Web of Science ®Google Scholar
• Hall K, Johansson BL, Povoa G, Thalme B. Serum levels of insulin-like growth factor (IGF) I, II and binding protein in diabetic adolescents treated with continuous subcutaneous insulin infusion. J Intern Med. 1989;225:273–278.
   PubMed Web of Science ®Google Scholar
• Patrinely JR, Osborn AG, Anderson RL, Whiting AS. Computed tomographic features of nonthyroid extraocular muscle enlargement. Ophthalmology. 1989;96:1038–1047.
   PubMed Web of Science ®Google Scholar
• Tristante G, Cordonnier M, Louryan S, Aguilera C, Unger J. The eye and acromegaly: a propos a case of ptosis. Bull Soc Belge Ophthalmol. 1992;243:1–6.
   Google Scholar
• Burgos R, Mateo C, Canton A, Hernandez C, Mesa J, Simo R. Vitreous levels of IGF-I, IGF-I binding protein, and IGF binding protein 3 in proliferative diabetic retinopathy: a case control. Diabetes Care. 2000;23:80–83.
   PubMed Web of Science ®Google Scholar
• Lee HC, Lee KW, Chung CH, Chung YS, Lee EJ, Lim SK, Kim KR, Huh KB, Lee SC, Kwon OW IGF-I of serum and vitreous fluid in patients with diabetic proliferative retinopathy. Diabetes Res Clin Pract. 1994;24:85–88.
   PubMed Web of Science ®Google Scholar
• Feldmann B, Jehle PM, Mohan S, Lang GE, Lang GK, Brueckel J, Boehm BO. Diabetic retinopathy is associated with decreased serum levels of free IGF-I and changes of IGF-binding proteins. Growth Horm IGF Res. 2000;10:53–59.
   Google Scholar
• Brismar K, Fernqvist-Forbes E, Wahren J, Hall K. Effect of insulin on the hepatic production of IGFBP-I, IGFBP-3, and IGF-I in insulin dependent diabetes. J Clin Endocrinol Metab. 1984;79:872–878.
   Google Scholar
• Pópova G, Roovete A, Hall K. Crossreaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol (Copenh). 1984; 107:563–570.
   Google Scholar
• Bang P, Erikssin U, Sara V, Wivall IL, Hall K. Comparison of acid ethanol extraction and gel filtration prior to IGF-I and IGF-II radioimmunoassays: Improvement of determination in acid ethanol extracts by use of truncated IGF-I as radioligand. Acta Endocrinol (Copenh). I99I;124:62o–629.
   Google Scholar
• Donaghy A, Ross R, Gimson A, Hughes SC, Holly J, Williams R. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins i and 3 in chronic liver disease. Hepatology. 1995;21:680–688.
   PubMed Web of Science ®Google Scholar
• Hilding A, Brismar K, Degerblad M, Thoren M, Hall K. Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects. J Gun Endocrinol Metab. 1995;80: 2646–2652.
   Google Scholar
• Saxena T, Maheshwari S, Goyal RK. Serum insulin assay: an important therpeutic tool in management of freshly diagnosed type 2 diabetes mellitus. J Assoc Physicians India. 2000;48: 815–817.
   Google Scholar
• Arnold DR, Moshayedi P, schoen TJ, Jones BE, Chader GJ, Waldbillig RJ. Distribution of IGF-I and -II, IGF binding proteins (IGFBPs) and IGFBP mRNA in ocular fluids and tissues: potential sites of synthesis of IGFBPs in aqueous and vitreous. Exp Eye Res. 1993;56:555–
   PubMed Web of Science ®Google Scholar
• Martin DM, Yee D, Feldman EL. Gene expression of the insulin-like growth factors and their receptors in cultured human retinal pigment epithelial cells. Brain Res Mol Brain Res. 1992;12:181–186.
   Google Scholar
• Grant MB, Mames RN, Fitzgerald C, Ellis EA, Aboufriekha M, Guy J. Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor. Diabetologia. 1993;36:282–291.
   PubMed Web of Science ®Google Scholar
• Baudouin C, Fredj-Reygrobellet D, Brignole F, Nègre F, Lapalus P, Gastaud P. Growth factors in vitreous and subretinal fluid cells from patients with proliferative vitreoretinopathy. Ophthalmic Res. 1993;25:52–59.
   PubMed Web of Science ®Google Scholar
• Spencer EM, Skover G, Hunt TK. Somatomedins: do they play a pivotal role in wound healing? Progr Gun Biol Res. 1988;266: 103–116.
   Google Scholar
• Lynch SE, Williams RC, Polson AM, Howell TH, Reddy MS, Zappa UE, Antoniades HN. A combination of platelet-derived and insulin-like growth factors enhances periodontal regeneration. J Clin PeriodontoL 1989;16:545–548.
   Google Scholar
• Algvere P. Vitrectomy after intracapsular cataract extraction in diabetic sequelae. Acta Ophthalmol (Copenh). 1979;57:530–542.
   PubMed Web of Science ®Google Scholar
• Arciniegas A, Velasquey G, Viteri E. Treating the complications of diabetic retinopathy with pars plana vitrectomy. Ann Ophthalmol. 1986; 18:233–235.
   Google Scholar
• Kaivonen M, Lavikainen P. Diabeettisen retinopatian esiintyminen ja hoidon tarve. Suomen Liiiikiiril.1983;38:1035–1041.
   Google Scholar
• Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 and more years. Arch Ophthalmol. 1984;102: 527–532.
   Google Scholar
• Ulbig MW, Wolfensberger TJ, Hiscott P, Ationu A, Carter ND, Gregor LI Insulin-like growth factor I (IGF-I) receptor/binding protein in human diabetic epiretinal membranes. German J Ophthalmol. 1995;4:264–268.
   PubMedGoogle Scholar
• Ristow HJ. Effect of insulin-like growth factor-I/somatomedin C on thymidine incorporation in cultured psoriatic keratinocytes after growth arrest in growth factor-free medium. Growth ReguL 1993;3:129–137.
   PubMedGoogle Scholar
• Waldbillig RI Pfeffer BA, schoen TJ, Adler AA, Shen-Orr Z, scavo L, LeRoith D, Chader GI Evidence for an insulin-like growth factor autocrine-paracrine system in the retinal photoreceptor-pigment epithelial cell complex. J Neurochem. 1991;57:1522–1533.
   Google Scholar
• Roth RA, Kiess W. Insulin-like growth factor receptors: Recent developments and methodologies. Growth ReguL 1994;4(suppl):31–38.
   Google Scholar
• Lamson G, Giudice LC, Rosenfield RG. Insulin-like growth factor binding proteins. Structural and molecular relationships. Growth Factors. 1991;5:19–28.
   PubMedGoogle Scholar
• Krywicki RF, Yee D. The insulin-like growth factor family of ligands, receptors, and binding proteins. Breast Cancer Res Treat. 1992;22:7–19.
   PubMed Web of Science ®Google Scholar
• Davis SR, Hodgkinson SC, Moore LG, Gluckman PD. Improved estimates of clearence of labelled insulin-like insulin-like growth factor-I carrier protein complexes from blood plasma of sheep. J Endocrinol. 1989;123:469–475.
   PubMed Web of Science ®Google Scholar
• Cascieri MA, Saperstein R, Hayes NS, Green BG, Chicehi GG, Applebaum J, Baynes ML. Serum half-time and biological activity of human insulin-like growth factor I which do not bind to serum binding proteins. Endocrinology. 1988;123: 373–381.
   Google Scholar
• Schoen TJ, Beebe DC, Clemmons DR, Chader GJ, Waldbillig RJ. Local synthesis and developmental regulation of avian vitreal insulin-like growth factor-binding proteins: a model for independent regulation in extravascular and vascular compartments. Endocrinology. 1992;131:2846–2854.
   Google Scholar